Diffusion-weighted imaging characteristics of biopsy-proven demyelinating brain lesions

Neurology

Volumn 78, Issue 21, 2012, Pages 1655-1662

  Abou Zeid, N ^a   Pirko, I ^a   Erickson, B ^a   Weigand, S D ^a   Thomsen, K M ^a   Scheithauer, B ^a   Parisi, J E ^a   Giannini, C ^a   Linbo, L ^a   Lucchinetti, C F ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN ABSCESS; BRAIN BIOPSY; BRAIN TUMOR; CANCER STAGING; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMYELINATING DISEASE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; ENCEPHALITIS; FEMALE; FUNCTIONAL NEUROIMAGING; HUMAN; HUMAN TISSUE; INTRACRANIAL TUBERCULOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 84863621227     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182574f66     Document Type: Article

References (35)

1. Annesley-Williams D, Farrell MA, Staunton H, Brett FM. Acute demyelination, neuropathological diagnosis, and clinical evolution. J Neuropathol Exp Neurol 2000;59: 477-489.
2. Ernst T, Chang L, Walot I, Huff K. Physiologic MRI of a tumefactive multiple sclerosis lesion. Neurology 1998;51: 1486-1488.
3. Cercignani M, Iannucci G, Filippi M. Diffusion-weighted imaging in multiple sclerosis. Ital J Neurol Sci 1999;20: S246-S249.
4. Rovaris M, Gass A, Bammer R, et al. Diffusion MRI in multiple sclerosis. Neurology 2005;65:1526-1532.
5. Schaefer PW, Grant PE, Gonzalez RG. Diffusionweighted MR imaging of the brain. Radiology 2000;217: 331-345.
6. Al-Okaili RN, Krejza J, Woo JH, et al. Intraaxial brain masses: MR imaging-based diagnostic strategy: Initial experience. Radiology 2007;243:539-550.
7. Karaarslan E, Arslan A. Diffusion weighted MR imaging in non-infarct lesions of the brain. Eur J Radiol 2008;65: 402-416.
8. Mukherji SK, Chenevert TL, Castillo M. Diffusionweighted magnetic resonance imaging. J Neuroophthalmol 2002;22:118-122.
9. Phuttharak W, Galassi W, Laopaiboon V, Laopaiboon M, Hesselink JR. ADC measurements in various patterns of multiple sclerosis lesions. J Med Assoc Thai 2006;89:196-204.
10. Tievsky AL, Ptak T, Farkas J. Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions. AJNR Am J Neuroradiol 1999;20:1491-1499.
11. Castriota-Scanderbeg A, Sabatini U, Fasano F, et al. Diffusion of water in large demyelinating lesions: A follow-up study. Neuroradiology 2002;44:764-767.
12. Rosso C, Remy P, Creange A, Brugieres P, Cesaro P, Hosseini H. Diffusion-weighted MR imaging characteristics of an acute strokelike form of multiple sclerosis. AJNR Am J Neuroradiol 2006;27:1006-1008.
13. Rovira A, Pericot I, Alonso J, Rio J, Grive E, Montalban X. Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large demyelinating brain lesions: Case report. AJNR Am J Neuroradiol 2002;23:989-994.
14. Kavanagh EC, Heran MK, Fenton DM, Lapointe JS, Nugent RA, Graeb DA. Diffusion-weighted imaging findings in Balo concentric sclerosis. Br J Radiol 2006;79:e28-e31.
15. Ball T, Malik O, Roncaroli F, Quest RA, Aviv RI. Apparent diffusion coefficient changes and lesion evolution in Balo's type demyelination- correlation with histopathology. Clin Radiol 2007;62:498-503.
16. Barboriak DP. Imaging of brain tumors with diffusionweighted and diffusion tensor MR imaging. Magn Reson Imaging Clin N Am 2003;11:379-401.
17. Lemort M, Canizares-Perez AC, Van der Stappen A, Kampouridis S. Progress in magnetic resonance imaging of brain tumours. Curr Opin Oncol 2007;19:616-622.
18. Stadnik TW, Chaskis C, Michotte A, et al. Diffusionweighted MR imaging of intracerebral masses: Comparison with conventional MR imaging and histologic findings. AJNR Am J Neuroradiol 2001;22:969-976.
19. Ebisu T, Tanaka C, Umeda M, et al. Discrimination of brain abscess from necrotic or cystic tumors by diffusionweighted echo planar imaging. Magn Reson Imaging 1996;14:1113-1116.
20. Kitis O, Altay H, Calli C, Yunten N, Akalin T, Yurtseven T. Minimum apparent diffusion coefficients in the evaluation of brain tumors. Eur J Radiol 2005;55:393-400.
21. Hart MN, Earle KM. Haemorrhagic and perivenous encephalitis: A clinical-pathological review of 38 cases. J Neurol Neurosurg Psychiatry 1975;38:585-591.
22. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-1489.
23. Schwartz KM, Erickson BJ, Lucchinetti C. Pattern of T2 hypointensity associated with ring-enhancing brain lesions can help to differentiate pathology. Neuroradiology 2006; 48:143-149.
24. Perneger TV. What's wrong with Bonferroni adjustments. BMJ 1998;316:1236-1238.
25. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43-46.
26. Beauchamp NJ Jr, Ulug AM, Passe TJ, van Zijl PC. MR diffusion imaging in stroke: Review and controversies. Radiographics 1998;18:1269-1283, discussion 1283-1265.
27. Fiebach JB, Jansen O, Schellinger PD, Heiland S, Hacke W, Sartor K. Serial analysis of the apparent diffusion coefficient time course in human stroke. Neuroradiology 2002;44:294-298.
28. Lutsep HL, Albers GW, DeCrespigny A, Kamat GN, Marks MP, Moseley ME. Clinical utility of diffusionweighted magnetic resonance imaging in the assessment of ischemic stroke. Ann Neurol 1997;41:574-580.
29. Sener RN. Diffusion magnetic resonance imaging patterns in metabolic and toxic brain disorders. Acta Radiol 2004; 45:561-570.
30. Moritani T, Shrier DA, Numaguchi Y, et al. Diffusionweighted echo-planar MR imaging: Clinical applications and pitfalls: A pictorial essay. Clin Imaging 2000;24:181-192.
31. Roychowdhury S, Maldjian JA, Grossman RI. Multiple sclerosis: Comparison of trace apparent diffusion coefficients with MR enhancement pattern of lesions. AJNR Am J Neuroradiol 2000;21:869-874.
32. Wiendl H, Weissert R, Herrlinger U, Krapf H, Kuker W. Diffusion abnormality in Balo's concentric sclerosis: Clues for the pathogenesis. Eur Neurol 2005;53:42-44.
33. Chen CJ, Ro LS, Chang CN, Ho YS, Lu CS. Serial MRI studies in pathologically verified Balo's concentric sclerosis. J Comput Assist Tomogr 1996;20:732-735.
34. Moore GR, Berry K, Oger JJ, Prout AJ, Graeb DA, Nugent RA. Balo's concentric sclerosis: Surviving normal myelin in a patient with a relapsing-remitting clinical course. Mult Scler 2001;7:375-382.
35. Stadelmann C, Ludwin S, Tabira T, et al. Tissue preconditioning may explain concentric lesions in Balo's type of multiple sclerosis. Brain 2005;128:979-987.